BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Stada, Cipla, Lee's Pharm, POA Pharma, Lunatus, Taiba, Pharma Mart, Salmaniya Gate, Lenis, and Sophos Biotech, and Avanos Medical.
Looking for a particular BioQ Pharma Incorporated employee's phone or email?
The BioQ Pharma Incorporated annual revenue was $23.7 million in 2026.
Ralph McNall is the Vice President Of Engineering of BioQ Pharma Incorporated.
19 people are employed at BioQ Pharma Incorporated.
BioQ Pharma Incorporated is based in San Francisco, California.
The NAICS codes for BioQ Pharma Incorporated are [32541, 32, 3254, 325].
The SIC codes for BioQ Pharma Incorporated are [283, 28].